Aurora Cannabis Lifts Outlook As CEO Hails Record Medical Marijuana Growth In Q2
Aurora Cannabis Inc. (NASDAQ:ACB) shares surged after the company reported fiscal second-quarter 2026 results, showing higher revenue and profitability, but a net loss compared to the prior year.
The company missed analyst earnings expectations but beat revenue expectations. Reported GAAP EPS was a loss of $0.19, missing the $0.02 consensus estimate, while sales totaled $65.64 million, topping the $63.79 million forecast.
Total net revenue rose 11% year over year to C$90.4 million from C$81.1 million, driven by growth in global medical cannabis and plant propagation.
Adjusted EBITDA increased 52% to C$15.4 million, and adjusted net income climbed to C$7.1 million, more than double the prior-year period.
Global medical marijuana net revenue grew 15% to a record …